BACKGROUND: Most diseases, including asthma, result from the interaction between environmental exposures and genetic variants. Functional variants of CD14 negatively affect lung function in farm workers and children exposed to animal allergens and endotoxin. OBJECTIVE: We hypothesized that CD14 polymorphisms interact with inhaled endotoxin, mouse allergen, or both to decrease airways function in laboratory animal workers. METHODS: Three hundred sixty-nine Caucasian workers completed a symptom and work exposure questionnaire, skin prick testing, and spirometry. Individual exposure estimates for endotoxin and murine allergen were calculated by weighting task-based breathing zone concentrations by time reported for each task and length of time in the current job. Real-time PCR was used to assess CD14/-1619, -550, and -159 alleles. Multiple linear regression predicting airways function included an interaction term between genotype and exposure. RESULTS: Workers at the highest quartile of the natural log-transformed cumulative endotoxin exposure and with the endotoxin-responsive CD14/-1619 G allele had significantly lower FEV(1) and forced expiratory flow, midexpiratory phase (FEF(25-75)) percent predicted compared with workers with an AA genotype, with no significant differences noted at lower endotoxin levels for either genotype. The gene-environment effect was marked for atopic workers. Laboratory animal allergy, murine allergen exposure, CD14/-159 or -550 genotype, and a gene-exposure interaction term for these genotypes and exposures did not predict changes in lung function. CONCLUSIONS: A significant gene-environment interaction affects airways function in laboratory animal workers. More highly endotoxin-exposed workers with CD14/-1619G alleles have significantly lower FEV(1) and FEF(25-75) percent predicted than those with CD14/-1619AA alleles. Atopic workers are particularly affected by cumulative endotoxin exposures. Copyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
BACKGROUND: Most diseases, including asthma, result from the interaction between environmental exposures and genetic variants. Functional variants of CD14 negatively affect lung function in farm workers and children exposed to animal allergens and endotoxin. OBJECTIVE: We hypothesized that CD14 polymorphisms interact with inhaled endotoxin, mouse allergen, or both to decrease airways function in laboratory animal workers. METHODS: Three hundred sixty-nine Caucasian workers completed a symptom and work exposure questionnaire, skin prick testing, and spirometry. Individual exposure estimates for endotoxin and murine allergen were calculated by weighting task-based breathing zone concentrations by time reported for each task and length of time in the current job. Real-time PCR was used to assess CD14/-1619, -550, and -159 alleles. Multiple linear regression predicting airways function included an interaction term between genotype and exposure. RESULTS: Workers at the highest quartile of the natural log-transformed cumulative endotoxin exposure and with the endotoxin-responsive CD14/-1619 G allele had significantly lower FEV(1) and forced expiratory flow, midexpiratory phase (FEF(25-75)) percent predicted compared with workers with an AA genotype, with no significant differences noted at lower endotoxin levels for either genotype. The gene-environment effect was marked for atopic workers. Laboratory animal allergy, murine allergen exposure, CD14/-159 or -550 genotype, and a gene-exposure interaction term for these genotypes and exposures did not predict changes in lung function. CONCLUSIONS: A significant gene-environment interaction affects airways function in laboratory animal workers. More highly endotoxin-exposed workers with CD14/-1619G alleles have significantly lower FEV(1) and FEF(25-75) percent predicted than those with CD14/-1619AA alleles. Atopic workers are particularly affected by cumulative endotoxin exposures. Copyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Authors: Anne R O'Donnell; Brett G Toelle; Guy B Marks; Catherine M Hayden; Ingrid A Laing; Jennifer K Peat; Jack Goldblatt; Peter N Le Souëf Journal: Am J Respir Crit Care Med Date: 2003-11-14 Impact factor: 21.405
Authors: Tricia D LeVan; Susanna Von Essen; Debra J Romberger; G Patrick Lambert; Fernando D Martinez; Monica M Vasquez; James A Merchant Journal: Am J Respir Crit Care Med Date: 2004-12-10 Impact factor: 21.405
Authors: Waltraud Eder; Walt Klimecki; Lizhi Yu; Erika von Mutius; Josef Riedler; Charlotte Braun-Fahrländer; Dennis Nowak; Fernando D Martinez Journal: J Allergy Clin Immunol Date: 2005-09 Impact factor: 10.793
Authors: April Zambelli-Weiner; Eva Ehrlich; Maria L Stockton; Audrey V Grant; Shu Zhang; Paul N Levett; Terri H Beaty; Kathleen C Barnes Journal: J Allergy Clin Immunol Date: 2005-06 Impact factor: 10.793
Authors: Stefano Guerra; I Carla Lohman; Tricia D LeVan; Anne L Wright; Fernando D Martinez; Marilyn Halonen Journal: Am J Reprod Immunol Date: 2004-09 Impact factor: 3.886
Authors: Ashley N Newton; Meghan Davis; Kirsten Koehler; Wayne Shreffler; Sharon Ahluwalia; Nervana Metwali; Peter S Thorne; Beverly J Paigen; Elizabeth C Matsui Journal: Ann Work Expo Health Date: 2017-10-01 Impact factor: 2.179
Authors: Tricia D LeVan; Lynette M Smith; Art J Heires; Ted R Mikuls; Jane L Meza; Lisa A Weissenburger-Moser; Debra J Romberger Journal: Respir Res Date: 2017-03-16